Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 13221 - 13227 of 13227 results

First page
Previous page
1323
Next page disabled
Next page disabled

TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (45/55 W/W; 100000 PA.S)

5VBE2X0WG0

Status:

Possibly Marketed Outside US

Source:

ANDA205622

(2000)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4ab335d1-19ee-4cd9-9776-8086645d19e4

First approved in 2000

Source:

ANDA205622

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4ab335d1-19ee-4cd9-9776-8086645d19e4

Class:

CONCEPT

DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S)

83D19O7250

Status:

Possibly Marketed Outside US

Source:

M001

(1998)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=163bceeb-ca74-413e-88b9-5c7bc9bbeb0d

First approved in 1998

Source:

M001

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=163bceeb-ca74-413e-88b9-5c7bc9bbeb0d

Class:

CONCEPT

POLAWAX POLYSORBATE

Q504PL8E0V

Status:

Possibly Marketed Outside US

Source:

NDA210566

(1990)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6994177-be9f-4c59-8330-e841c8239a0e

First approved in 1984

Source:

ANDA088042

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2c7fee2c-6f57-4de4-8803-98c0b31b07c3

Class:

CONCEPT

TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 5000000 PA.S)

9N5G1G3D3H

Status:

Possibly Marketed Outside US

Source:

ANDA076258

(1968)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac5785b7-19ec-4715-b05d-cb2c70de4448

First approved in 1968

Source:

ANDA076258

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac5785b7-19ec-4715-b05d-cb2c70de4448

Class:

CONCEPT

EDRECOLOMAB

0KYI9U9FSJ

Status:

Possibly Marketed Outside US

Source:

WHO-ATC:EDRECOLOMAB

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/0KYI9U9FSJ

Class:

CONCEPT

HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN RESIDUES 2-472 ANTIGEN

M7H9CF9G0Z

Status:

Possibly Marketed Outside US

Source:

NCT03180034: Phase 4 Interventional Active, not recruiting Human Papillomavirus Infection

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03180034

Class:

CONCEPT

HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN

7XB76X2V7T

Status:

Possibly Marketed Outside US

Source:

NCT03180034: Phase 4 Interventional Active, not recruiting Human Papillomavirus Infection

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03180034

Class:

CONCEPT

Concept

TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (45/55 W/W; 100000 PA.S)

Concept

DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S)

Concept

POLAWAX POLYSORBATE

Concept

TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 5000000 PA.S)

Concept

EDRECOLOMAB

Concept

HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN RESIDUES 2-472 ANTIGEN

Concept

HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN

Showing 13221 - 13227 of 13227 results

First page
Previous page
1323
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1